[1]
Al-Rawashde, F.A. et al. 2024. In silico Evaluation of the Antileukemia Activities of Thymoquinone by Targeting FLT3-ITD and BCR-ABL Signaling in Myeloid leukemia. Tropical Journal of Natural Product Research (TJNPR). 8, 6 (Jun. 2024), 7447–7451. DOI:https://doi.org/10.26538/tjnpr/v8i6.17.